FDA Approves Gimoti (metoclopramide) Nasal Spray for Diabetic Gastroparesis
FDA Approves Gimoti (metoclopramide) Nasal Spray for Diabetic Gastroparesis Print this page SOLANA BEACH, Calif., June 19, 2020 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for… Read More »